Literature DB >> 32889075

Vasculitis and aortitis: COVID-19 challenging complications.

Antonio Manenti1, Alberto Farinetti1, Gianrocco Manco1, Annavittoria Mattioli2.   

Abstract

Entities:  

Year:  2020        PMID: 32889075      PMCID: PMC7462784          DOI: 10.1016/j.jvs.2020.08.029

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


× No keyword cloud information.
Some pathophysiologic observations about thrombosis in small/medium sized arteries in coronavirus disease-19 (COVID-19) are of interest in study from Bellosta et al. This complication can be correlated with two main processes. The first is an acute endotheliitis, where endothelial cells, inhabited by virions, become infiltrated by neutrophils and mononuclear elements, leading to an accelerated apoptosis and a lymphocytic endotheliitis, and to an inflammatory/prothrombotic milieu. This correlates with a cell-mediated immune response. Second, in the same arteries in later stages of the disease, there is peri/panarteritis, consisting of an extended infiltration by the same inflammatory elements, followed by an accelerated karyolysis, accumulation of apoptotic bodies, caspase proteic granules, and fibrinoid substances, indicating a leukocytoclastic vasculitis. Interestingly, this inflammatory reaction is followed by deposition of polyclonal antigen-antibody immune complexes IgG, prevalent, IgA and IgM, of C3 complement fraction proteins, suggesting a type III hypersensitive acute vasculitis, equally predisposing to thrombosis. This finding indicates a host's dysregulated humoral response. We have observed that an equivalent pathology can involve large-sized arteries as well, typically the aorta, with parietal thromboses often incidentally discovered and not always amenable to the sole blood hypercoagulability. In the absence of adequate histopathologic data, some aspects can be explained translating elements from the mechanisms presented in this letter, namely, the lymphocytic endotheliitis. In fact, we interpret an aortic parietal thrombosis in the course of COVID-19 as an infectious aortitis occurring during its viremic phase, when the aortic endothelium, largely provided of angiotensin-converting enzyme-2 receptors, is directly attacked by virions, leading to an endotheliitis that could later by complicated by a hypersensitive vasculitis. This process can be favored by a preexisting pathology, typically atherosclerotic plaques, mainly if ulcerated, or, more generally, by a basal condition of endothelial dysfunction. However, we do not exclude the importance of coexisting facilitating hemodynamic conditions, such as a turbulent flow and a reduced parietal elasticity, which are common in the aorta of elderly patients or after endovascular procedures. To our knowledge, this active inflammatory and non-necrotic/degenerative pathology did not cause intramural hematomas or dissections. However, we suggest further research about possible complications, such as extended thrombosis or secondary aneurysm.
  5 in total

Review 1.  PET/CT for Diagnosis and Management of Large-Vessel Vasculitis.

Authors:  Matthieu Pelletier-Galarneau; Terrence D Ruddy
Journal:  Curr Cardiol Rep       Date:  2019-03-18       Impact factor: 2.931

2.  Endothelial cell infection and endotheliitis in COVID-19.

Authors:  Zsuzsanna Varga; Andreas J Flammer; Peter Steiger; Martina Haberecker; Rea Andermatt; Annelies S Zinkernagel; Mandeep R Mehra; Reto A Schuepbach; Frank Ruschitzka; Holger Moch
Journal:  Lancet       Date:  2020-04-21       Impact factor: 79.321

3.  Type 3 hypersensitivity in COVID-19 vasculitis.

Authors:  Luca Roncati; Giulia Ligabue; Luca Fabbiani; Claudia Malagoli; Graziana Gallo; Beatrice Lusenti; Vincenzo Nasillo; Antonio Manenti; Antonio Maiorana
Journal:  Clin Immunol       Date:  2020-05-29       Impact factor: 3.969

4.  Acute limb ischemia in patients with COVID-19 pneumonia.

Authors:  Raffaello Bellosta; Luca Luzzani; Giuseppe Natalini; Matteo Alberto Pegorer; Luca Attisani; Luisa Giuseppina Cossu; Camillo Ferrandina; Alessandro Fossati; Elena Conti; Ruth L Bush; Gabriele Piffaretti
Journal:  J Vasc Surg       Date:  2020-04-29       Impact factor: 4.268

Review 5.  The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection.

Authors:  Stéphanie Pons; Sofiane Fodil; Elie Azoulay; Lara Zafrani
Journal:  Crit Care       Date:  2020-06-16       Impact factor: 9.097

  5 in total
  9 in total

Review 1.  The impact of the COVID-19 pandemic on vascular surgery: Health care systems, economic, and clinical implications.

Authors:  Ryan Gupta; Nicolas J Mouawad; Jeniann A Yi
Journal:  Semin Vasc Surg       Date:  2021-07-17       Impact factor: 1.000

2.  Aortitis in COVID-19.

Authors:  Pravash Dhakal; Sushmita Khadka; Jackie A Clowes; Raja Chandra Chakinala
Journal:  IDCases       Date:  2021-03-10

Review 3.  Aortic Pathology During COVID - 19 Pandemics. Clinical Reports in Literature and Open Questions on the two Co-Occurring Conditions.

Authors:  Valeria Silvestri; Gregorio Egidio Recchia
Journal:  Ann Vasc Surg       Date:  2021-04-03       Impact factor: 1.466

4.  Carboxypeptidase B blocks ex vivo activation of the anaphylatoxin-neutrophil extracellular trap axis in neutrophils from COVID-19 patients.

Authors:  Yue Zhang; Kai Han; Chunjing Du; Rui Li; Jingyuan Liu; Hui Zeng; Liuluan Zhu; Ang Li
Journal:  Crit Care       Date:  2021-02-08       Impact factor: 9.097

Review 5.  Mimickers of Large Vessel Giant Cell Arteritis.

Authors:  André Ramon; Hélène Greigert; Paul Ornetti; Bernard Bonnotte; Maxime Samson
Journal:  J Clin Med       Date:  2022-01-19       Impact factor: 4.241

6.  Toward a unified pathophysiology in COVID-19 acute aortopathies.

Authors:  Luca Roncati; Antonio Manenti; Alberto Farinetti; Gianrocco Manco; Anna Vittoria Mattioli
Journal:  J Vasc Surg       Date:  2021-11       Impact factor: 4.268

Review 7.  Spectrum of Large- and Medium-Vessel Vasculitis in Adults: Neoplastic, Infectious, Drug-Induced, Autoinflammatory, and Primary Immunodeficiency Diseases.

Authors:  Fabian Lötscher; Roxana Pop; Pascal Seitz; Mike Recher; Luca Seitz
Journal:  Curr Rheumatol Rep       Date:  2022-08-03       Impact factor: 4.686

Review 8.  Rheumatological complications of Covid 19.

Authors:  Hannah Zacharias; Shirish Dubey; Gouri Koduri; David D'Cruz
Journal:  Autoimmun Rev       Date:  2021-07-05       Impact factor: 9.754

9.  Relapse of microscopic polyangiitis after vaccination against COVID-19: A case report.

Authors:  Edoardo Conticini; Miriana d'Alessandro; Laura Bergantini; Elena Bargagli; Francesco Gentili; Maria Antonietta Mazzei; Luca Cantarini; Bruno Frediani
Journal:  J Med Virol       Date:  2021-07-20       Impact factor: 20.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.